The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cells

OncoImmunology

Volumn 3, Issue 6, 2014, Pages

  Grage Griebenow, Evelin ^a   Schäfer, Heiner ^b   Sebens, Susanne ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Laboratory of Molecular Gastroenterology and Hepatology   (Germany)

Author keywords

Immune evasion; L1CAM; Pancreatic cancer; Tumor microenvironment; Tumor associated inflammation

Indexed keywords

CD171 ANTIGEN; INTERLEUKIN 1BETA; LYMPHOCYTE ANTIGEN; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD4+CD25-CD69+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; PANCREAS ADENOCARCINOMA; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84906490714     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.29382     Document Type: Article

References (10)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j. cell.2011.02.013
2. Byrne WL, Mills KH, Lederer JA, O'Sullivan GC. Targeting regulatory T cells in cancer. Cancer Res 2011; 71:6915-20; PMID:22068034; http://dx.doi. org/10.1158/0008-5472.CAN-11-1156
3. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6:295-307; PMID:16557261; http://dx.doi.org/10.1038/ nri1806
4. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006; 12:5423-34; PMID:17000676; http://dx.doi. org/10.1158/1078-0432.CCR-06-0369
5. Tan MC, Goedegebuure PS, Belt BA, Flaherty B, Sankpal N, Gillanders WE, Eberlein TJ, Hsieh CS, Linehan DC. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 2009; 182:1746-55; PMID:19155524; http://dx.doi. org/10.4049/jimmunol.182.3.1746
6. Nummer D, Suri-Payer E, Schmitz-Winnenthal H, Bonertz A, Galindo L, Antolovich D, Koch M, Büchler M, Weitz J, Schirrmacher V, et al. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma. J Natl Cancer Inst 2007; 99:1188-99; PMID:17652277; http://dx.doi.org/10.1093/jnci/djm064
7. Moo-Young TA, Larson JW, Belt BA, Tan MC, Hawkins WG, Eberlein TJ, Goedegebuure PS, Linehan DC. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. J Immunother 2009; 32:12-21; PMID:19307989; http://dx.doi. org/10.1097/CJI.0b013e318189f13c
8. Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B, et al. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 2009; 69:4517-26; PMID:19435915; http://dx.doi. org/10.1158/0008-5472.CAN-08-3493
9. Grage-Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag-Wolf S, Goebel L, Vogel I, Becker T, Ebsen M, et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol 2014; (Forthcoming); PMID:24746181; http://dx.doi.org/10.1016/j.molonc.2014.03.001
10. Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005; 26:136-40; PMID:15745855; http://dx.doi.org/10.1016/j. it.2004.12.006